Home :: Project :: Products

The company proposes to set up manufacturing facilities for an aggregate installed annual capacity of 710 kgs bulk active pharmaceutical ingredients of high value biopharmaceuticals - Tacrolimus, Daunomycin and Hyaluronic acid (Pharma grade).  

A number of other products like Rapamycin, Mycophenolic acid, Clavulenic acid, Vancomycin and Monoclonal antibodies (anti-cancer), and their formulations will be introduced in phases.

Products: Installed Capacities

Product Capacity (kgs/annum)
Tacrolimus 60
Daunomycin 250
Hyaluronic Acid – Pharma 400
Total Installed capacity 710